What is LOAN's health score?

MANHATTAN BRIDGE CAPITAL, INC (LOAN) has a TradeApes health score of 65 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is LOAN's estimated fair value?

Based on our 5-year discounted cash flow model, MANHATTAN BRIDGE CAPITAL, INC's estimated fair value is $5.42 per share, representing a 27.8% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is LOAN undervalued or overvalued?

Our model currently rates LOAN as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for LOAN... Refresh in a moment for the full analysis.

MANHATTAN BRIDGE CAPITAL, INC (LOAN)

Real Estate Undervalued medium healthy

$4.24

Updated: 2026-06-06

TradeApes Score

Financial Strength

70 Healthy

Operating Trend

50 Mixed

Relative Value

75 Strong

Capital Allocation

55 Mixed

Risk

80 Strong

Est. Fair Value $5.42

DCF Upside +27.8%

Sector Rank #1214 of 1817

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Thin interest coverage — EBIT covers interest just 2–4×

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.